Aspire Biopharma Holdings, Inc.
Price Action
Technical Summary
DOWNTRENDAspire Biopharma Holdings, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is leading (RS Rating: 99), indicating clear outperformance against the broad market. Earnings contraction of 51% provides fundamental context to the price action. Investors should exercise caution due to high volatility (198% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.43 | -7.37% | BELOW |
| 50 SMA | $2.49 | -47.00% | BELOW |
| 100 SMA | $5.38 | -75.47% | BELOW |
| 150 SMA | $9.30 | -85.81% | BELOW |
| 200 SMA | $10.48 | -87.41% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ASBP in an uptrend right now?
ASBP has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is ASBP overbought or oversold?
ASBP's RSI (14) is 41. The stock is in neutral territory, neither overbought nor oversold.
Is ASBP outperforming the market?
ASBP has a Relative Strength (RS) Rating of 99 out of 99. Yes, ASBP is a market leader, outperforming 99% of all stocks over the past 12 months.
Where is ASBP in its 52-week range?
ASBP is trading at $1.32, which is 54% of its 52-week high ($2.45) and 53% above its 52-week low ($0.05).
How volatile is ASBP?
ASBP has a Beta of 1.61 and 52-week volatility of 198%. It's more volatile than the S&P 500 - expect bigger swings.